Check out our most popular compounded medications! Get Started
The Phenazopyridine HCl 150 mg/Butalbital 15 mg/Hyoscyamine Sulfate 0.3 mg Capsules are a compounded prescription medication. Enclosed in gelatin or vegetarian shells, these capsules provide an accurate dosage of the active ingredients. They are a convenient and easy-to-swallow treatment for conditions such as Interstitial Cystitis, Urinary Tract Infection, Bladder Pain Syndrome, Dysuria, and Hematuria.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Phenazopyridine HCl 150 mg/Butalbital 15 mg/Hyoscyamine Sulfate 0.3 mg Capsules formulation is a meticulously compounded medication, specifically engineered to address a range of urinary tract conditions. These conditions encompass Interstitial Cystitis, Urinary Tract Infection, Bladder Pain Syndrome, Dysuria, and Hematuria. Each active ingredient in this formulation plays a distinct role, contributing to the overall efficacy of the medication in providing relief from these conditions.
Phenazopyridine HCl serves as an analgesic and urinary tract antiseptic. It functions by alleviating pain and inflammation in the urinary tract, providing relief from discomfort associated with these conditions. Butalbital, a sedative-hypnotic, is incorporated in the formulation to help mitigate anxiety and tension that often accompany these urinary tract conditions. Hyoscyamine Sulfate, an anticholinergic, is included in the formulation to help diminish bladder spasms and pain, further augmenting the overall effectiveness of the medication.
This compounded formulation is encased in two gelatin or vegetarian shells, forming a solid dosage form. This design facilitates convenient and easy swallowing, ensuring that patients receive a precise dosage of the active ingredients. This accuracy is vital in managing the symptoms of the aforementioned conditions, providing patients with the relief they require.
The solid dosage form also offers advantages such as stability, portability, and ease of administration. It allows for a controlled release of the medication, ensuring a consistent therapeutic effect. This formulation is a testament to the advancements in pharmaceutical compounding, combining multiple active ingredients into a single, easy-to-administer capsule.
Moreover, the solid dosage form provides a protective barrier for the active ingredients, enhancing their stability and shelf-life. It also allows for the potential of sustained or delayed release of the medication, offering a more controlled and consistent therapeutic effect. This is particularly beneficial in managing chronic conditions, where maintaining a steady level of medication in the body can significantly improve treatment outcomes.
If you have any queries about this formulation or its role in treating Interstitial Cystitis, Urinary Tract Infection, Bladder Pain Syndrome, Dysuria, and Hematuria, please do not hesitate to reach out. Our team of experienced compounding pharmacists is here to provide the information and support you need. We are dedicated to delivering high-quality, personalized medication solutions to meet the unique needs of each patient.
This compounded formulation combines Phenazopyridine HCl 150 mg, Butalbital 15 mg, and Hyoscyamine Sulfate 0.3 mg in a capsule form. The medication is specifically designed to treat conditions such as Interstitial Cystitis, Urinary Tract Infection, Bladder Pain Syndrome, Dysuria, and Hematuria. It is crucial to note that this formulation is not suitable for patients with a known hypersensitivity to any of the components.
Extra caution is advised when prescribing this formulation to patients with renal impairment, as the active ingredients may accumulate in the body, potentially leading to adverse effects. Patients should be closely monitored for signs of adverse effects, which may include nausea, vomiting, dizziness, and drowsiness. It is recommended that patients avoid activities requiring alertness, such as driving or operating machinery, while taking this medication. Concurrent consumption of alcohol should also be avoided, as it may increase the risk of adverse effects.
Patients are advised to take this formulation with food or milk to minimize the risk of gastrointestinal upset. In the event of any adverse symptoms, patients should immediately contact their healthcare provider. This formulation is designed to provide a precise dosage of the active ingredients, enclosed in two gelatin or vegetarian shells for easy swallowing and convenience. The capsule form ensures the medication is delivered in a controlled manner, providing the patient with the exact dosage required for their treatment.
It is important to follow the prescribed dosage and not to exceed the recommended dose. Overdosing can lead to serious health complications. Patients should also be aware that this medication may interact with other drugs, so it is important to inform the healthcare provider of any other medications being taken. Regular follow-ups with the healthcare provider are necessary to monitor the patient's progress and to make any necessary adjustments to the treatment plan.
Phenazopyridine HCl 150 mg/Butalbital 15 mg/Hyoscyamine Sulfate 0.3 mg Capsules is a meticulously compounded formulation primarily designed for the management of various urinary tract conditions. These conditions include Interstitial Cystitis, Urinary Tract Infection, Bladder Pain Syndrome, Dysuria, and Hematuria. This unique combination medication combines the analgesic and anesthetic properties of Phenazopyridine HCl, the sedative effects of Butalbital, and the anticholinergic benefits of Hyoscyamine Sulfate, creating a synergistic effect that enhances the overall effectiveness of the medication.
Phenazopyridine HCl works by numbing the bladder and urinary tract, providing relief from pain and discomfort. Butalbital, a sedative, aids in relaxing the bladder muscles and reducing spasms. Hyoscyamine Sulfate, an anticholinergic agent, further contributes to the reduction of bladder spasms and pain, enhancing the overall effectiveness of the medication.
This medication is typically administered orally, usually two to three times daily, or as directed by a healthcare professional. Adherence to the prescribed dosage is crucial to ensure the effectiveness of the medication and to avoid potential side effects. Hydration is also an important aspect while on this medication, as drinking ample fluids aids in flushing out the bladder and urinary tract, promoting overall urinary health.
Common side effects of this medication may include drowsiness, dizziness, headache, nausea, vomiting, and dry mouth. It is essential to seek immediate medical attention if any of these side effects persist or worsen. Always consult with your healthcare provider for any questions or concerns regarding this medication. It is important to remember that this medication has been prescribed because the healthcare provider has judged that the benefit to you is greater than the risk of side effects.
It is also important to note that this medication should not be used in patients with a history of hypersensitivity to any of its components. Additionally, patients with certain medical conditions such as glaucoma, myasthenia gravis, and certain types of gastrointestinal obstructions may need to avoid this medication or use it with caution under the supervision of a healthcare provider. Always inform your healthcare provider of your complete medical history and current medications to ensure this medication is safe for you.
This compounded formulation combines Phenazopyridine HCl 150 mg, Butalbital 15 mg, and Hyoscyamine Sulfate 0.3 mg. The active ingredients are precisely measured and enclosed within two gelatin or vegetarian shells, ensuring accurate dosage and facilitating easy swallowing for patients.
This versatile formulation can be used to manage a variety of conditions. It can also be a potential treatment option for irritable bowel syndrome, helping to alleviate symptoms like abdominal pain, bloating, and constipation.
In addition to its gastrointestinal benefits, this formulation can also be used to treat bladder spasms, which can cause pain and difficulty urinating. It may also be used to alleviate the symptoms of interstitial cystitis, such as bladder pain, urinary frequency, and urgency.
It's important to note that the effectiveness of this formulation can vary from person to person and depending on the specific condition being treated. Always consult with a healthcare professional before starting any new medication. If you have any questions about the use of this formulation for any of these conditions, please do not hesitate to reach out to a healthcare provider.
Therefore, it's always recommended to discuss your specific needs and concerns with a healthcare provider before starting any new medication regimen.
This is a compounded medication that combines Phenazopyridine HCl, Butalbital, and Hyoscyamine Sulfate in specific doses. It is enclosed in two gelatin or vegetarian shells to form a solid dosage form that is easy to swallow and provides a precise dosage of the active ingredients.
Phenazopyridine HCl is typically used to relieve symptoms caused by irritation of the urinary tract, Butalbital is often used to treat tension headaches, and Hyoscyamine Sulfate is used to treat a variety of stomach and intestinal problems. The combination of these three ingredients can address multiple symptoms at once.
This medication should be taken orally as directed by your healthcare provider. The capsule form allows for easy swallowing and precise dosage.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Side effects can vary depending on the individual, but may include dizziness, drowsiness, blurred vision, dry mouth, or upset stomach. If any of these effects persist or worsen, notify your healthcare provider immediately.
Consult your healthcare provider before taking this medication if you are pregnant or breastfeeding. They will be able to advise you on the potential risks and benefits.
Before starting this medication, inform your healthcare provider about any other drugs you are currently taking, as there may be potential interactions. Always follow your healthcare provider's instructions.
If you suspect an overdose, seek immediate medical attention. Symptoms of overdose may include severe drowsiness, slow or shallow breathing, severe dizziness, or fainting.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
No, the capsule should not be opened or crushed. It is designed to be swallowed whole to ensure the correct dosage is received.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
